Skip to content

Study · Animal study (in vivo) · mouse · 2021

6 results

The neuroprotection of cerebrolysin after spontaneous intracerebral hemorrhage through regulates necroptosis via Akt/ GSK3β signaling pathway.

Tao Y, Xu Y, Shen M, Feng X, Wu Y, Wu Y, Shen L, Wang Y

Acta cirurgica brasileira22 Nov 2021Cited by 5 (Europe PMC)

Summary

PurposeSpontaneous intracerebral hemorrhage (ICH) is a major cause of death and disability with a huge economic burden worldwide. Cerebrolysin (CBL) has been previously used as a nootropic drug. Necroptosis is a programmed cell death mechanism that plays a vital role in neuronal cell death after ICH. However, the precise role of necroptosis in CBL neuroprotection following ICH has not been confirmed.MethodsIn the present study, we aimed to investigate the neuroprotective effects and potential molecular mechanisms of CBL in ICH-induced early brain injury (EBI) by regulating neural necroptosis in the C57BL/6 mice model. Mortality, neurological score, brain water content, and neuronal death were evaluated by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining, Evans blue extravasation, Western blotting, and quantitative real-time polymerase chain reaction (PCR).ResultsThe results show that CBL treatment markedly increased the survival rate, neurological score, and neuron survival, and downregulated the protein expression of RIP1 and RIP3, which indicated that CBL-mediated inhibition of necroptosis, and ameliorated neuronal death after ICH. The neuroprotective capacity of CBL is partly dependent on the Akt/GSK3β signaling pathway.ConclusionsCBL improves neurological outcomes in mice and reduces neuronal death by protecting against neural necroptosis.
CC BYText from Europe PMC. Highlighted sentences are the source of results.

Results from this study6

6 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In mice with intracerebral hemorrhage, Cerebrolysin increased survival rate.

    In plain wordsIn mice with brain hemorrhage, Cerebrolysin increased survival.

    Outcome
    IncreaseSurvival rate
    Study

    micen: not reported in source

    C57BL/6 mice with intracerebral hemorrhage
    Outcome group
    Mortality · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The results show that CBL treatment markedly increased the survival rate, neurological score, and neuron survival, and downregulated the protein expression of RIP1 and RIP3, which indicated that CBL-mediated inhibition of necroptosis, and ameliorated neuronal death after ICH.
    1 context sentence
    Summary · context
    In the present study, we aimed to investigate the neuroprotective effects and potential molecular mechanisms of CBL in ICH-induced early brain injury (EBI) by regulating neural necroptosis in the C57BL/6 mice model.
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In mice with intracerebral hemorrhage, Cerebrolysin increased neurological score.

    In plain wordsIn mice with brain hemorrhage, Cerebrolysin increased neurological score.

    Outcome
    IncreaseNeurological score
    Study

    micen: not reported in source

    C57BL/6 mice with intracerebral hemorrhage
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The results show that CBL treatment markedly increased the survival rate, neurological score, and neuron survival, and downregulated the protein expression of RIP1 and RIP3, which indicated that CBL-mediated inhibition of necroptosis, and ameliorated neuronal death after ICH.
    1 context sentence
    Summary · context
    In the present study, we aimed to investigate the neuroprotective effects and potential molecular mechanisms of CBL in ICH-induced early brain injury (EBI) by regulating neural necroptosis in the C57BL/6 mice model.
  3. 03AnimalAnimal study (in vivo)Efficacy outcome

    In mice with intracerebral hemorrhage, Cerebrolysin increased neuron survival and reduced neuronal death.

    In plain wordsIn mice with brain hemorrhage, Cerebrolysin increased nerve cell survival.

    Outcome
    IncreaseNeuron survival
    Study

    micen: not reported in source

    C57BL/6 mice with intracerebral hemorrhage
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The results show that CBL treatment markedly increased the survival rate, neurological score, and neuron survival, and downregulated the protein expression of RIP1 and RIP3, which indicated that CBL-mediated inhibition of necroptosis, and ameliorated neuronal death after ICH.
    1 context sentence
    Summary · context
    In the present study, we aimed to investigate the neuroprotective effects and potential molecular mechanisms of CBL in ICH-induced early brain injury (EBI) by regulating neural necroptosis in the C57BL/6 mice model.
  4. 04AnimalAnimal study (in vivo)Mechanism

    In mice with intracerebral hemorrhage, Cerebrolysin reduced RIP1 protein expression.

    In plain wordsIn mice with brain hemorrhage, Cerebrolysin reduced RIP1 protein expression.

    Outcome
    DecreaseRIP1 protein expression
    Study

    micen: not reported in source

    C57BL/6 mice with intracerebral hemorrhage
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The results show that CBL treatment markedly increased the survival rate, neurological score, and neuron survival, and downregulated the protein expression of RIP1 and RIP3, which indicated that CBL-mediated inhibition of necroptosis, and ameliorated neuronal death after ICH.
    1 context sentence
    Summary · context
    In the present study, we aimed to investigate the neuroprotective effects and potential molecular mechanisms of CBL in ICH-induced early brain injury (EBI) by regulating neural necroptosis in the C57BL/6 mice model.
  5. 05AnimalAnimal study (in vivo)Mechanism

    In mice with intracerebral hemorrhage, Cerebrolysin reduced RIP3 protein expression.

    In plain wordsIn mice with brain hemorrhage, Cerebrolysin reduced RIP3 protein expression.

    Outcome
    DecreaseRIP3 protein expression
    Study

    micen: not reported in source

    C57BL/6 mice with intracerebral hemorrhage
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The results show that CBL treatment markedly increased the survival rate, neurological score, and neuron survival, and downregulated the protein expression of RIP1 and RIP3, which indicated that CBL-mediated inhibition of necroptosis, and ameliorated neuronal death after ICH.
    1 context sentence
    Summary · context
    In the present study, we aimed to investigate the neuroprotective effects and potential molecular mechanisms of CBL in ICH-induced early brain injury (EBI) by regulating neural necroptosis in the C57BL/6 mice model.
  6. 06AnimalAnimal study (in vivo)Mechanism

    In mice with intracerebral hemorrhage, Cerebrolysin neuroprotection partly depended on Akt/GSK3β signaling.

    In plain wordsIn mice with brain hemorrhage, Cerebrolysin protection partly depended on Akt/GSK3β signaling.

    Outcome
    Not applicableAkt/GSK3β pathway dependence
    Study

    micen: not reported in source

    C57BL/6 mice with intracerebral hemorrhage
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The neuroprotective capacity of CBL is partly dependent on the Akt/GSK3β signaling pathway.
    1 context sentence
    Summary · context
    In the present study, we aimed to investigate the neuroprotective effects and potential molecular mechanisms of CBL in ICH-induced early brain injury (EBI) by regulating neural necroptosis in the C57BL/6 mice model.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.